6-42236246-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001395490.1(TRERF1):c.3025C>A(p.Pro1009Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,608,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395490.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRERF1 | NM_001395490.1 | c.3025C>A | p.Pro1009Thr | missense_variant | 16/18 | ENST00000695948.1 | NP_001382419.1 | |
LOC105375061 | XR_001744122.2 | n.538-170G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRERF1 | ENST00000695948.1 | c.3025C>A | p.Pro1009Thr | missense_variant | 16/18 | NM_001395490.1 | ENSP00000512293 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000368 AC: 9AN: 244710Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132392
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1456238Hom.: 0 Cov.: 32 AF XY: 0.00000828 AC XY: 6AN XY: 724502
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.3025C>A (p.P1009T) alteration is located in exon 16 (coding exon 12) of the TRERF1 gene. This alteration results from a C to A substitution at nucleotide position 3025, causing the proline (P) at amino acid position 1009 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at